Free Trial

Cadrenal Therapeutics (CVKD) SEC Filings & 10K Form

$0.41
-0.01 (-2.37%)
(As of 05/22/2024 ET)

Recent Cadrenal Therapeutics SEC Filings

DateFilerForm TypeView
05/09/2024
5:23 AM
Cadrenal Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/10/2024
4:30 PM
Cadrenal Therapeutics (Issuer)
Pham Quang X (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
8:26 AM
Cadrenal Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
11:15 PM
Cadrenal Therapeutics (Filer)
Form EFFECT
03/20/2024
11:15 PM
Cadrenal Therapeutics (Filer)
Form EFFECT
03/12/2024
7:37 AM
Cadrenal Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2024
7:04 AM
Cadrenal Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/11/2024
8:15 AM
Cadrenal Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
7:00 AM
Cadrenal Therapeutics (Filer)
Form 8-K/A
02/14/2024
2:34 PM
ARMISTICE CAPITAL, LLC (Filed by)
Cadrenal Therapeutics (Subject)
Form SC 13G
02/12/2024
8:41 PM
Cadrenal Therapeutics (Issuer)
Pham Quang X (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
8:42 PM
Cadrenal Therapeutics (Subject)
Pham Quang X (Filed by)
Form SC 13G
01/19/2024
6:38 PM
Cadrenal Therapeutics (Issuer)
LOSORDO DOUGLAS W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
6:38 PM
Cadrenal Therapeutics (Issuer)
WILSON GLYNN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
6:39 PM
Cadrenal Therapeutics (Issuer)
Szot Matthew K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
6:40 PM
Cadrenal Therapeutics (Issuer)
Pham Quang X (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
6:41 PM
Cadrenal Therapeutics (Issuer)
Lisicki Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
6:41 PM
Cadrenal Therapeutics (Issuer)
MURPHY JOHN RAYMOND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
6:41 PM
Cadrenal Therapeutics (Issuer)
Zelenkofske Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
8:15 AM
Cadrenal Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
7:00 AM
Cadrenal Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2023
4:04 PM
Cadrenal Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
4:32 PM
Cadrenal Therapeutics (Issuer)
MURPHY JOHN RAYMOND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
2:28 PM
Cadrenal Therapeutics (Issuer)
Pham Quang X (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
5:05 AM
Cadrenal Therapeutics (Issuer)
Pham Quang X (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
3:55 PM
Cadrenal Therapeutics (Filer)
Form DEF 14A
08/28/2023
3:58 PM
Cadrenal Therapeutics (Filer)
Form ARS
08/18/2023
5:06 AM
Cadrenal Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
3:10 PM
Cadrenal Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
8:16 AM
Cadrenal Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
5:06 AM
Cadrenal Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2023
5:06 AM
Cadrenal Therapeutics (Filer)
Form 424B3
07/30/2023
11:15 PM
Cadrenal Therapeutics (Filer)
Form EFFECT
07/24/2023
4:25 PM
Cadrenal Therapeutics (Issuer)
Lisicki Robert (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/24/2023
4:26 PM
Cadrenal Therapeutics (Issuer)
Lisicki Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
8:20 AM
Cadrenal Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2023
8:15 AM
Cadrenal Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/14/2023
3:52 PM
Cadrenal Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CVKD) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners